Search

everythinglearnresearchcommunity

for

Search:↓

Removing a specific gene in certain skin cells causes hair loss in mice by disrupting hair follicle development.

Changing CDK4 levels affects the number of stem cells in mouse hair follicles.

Removing HIF-P4H-2 from certain skin cells in mice causes hair loss on the body but not the head.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Mesotherapy is more effective than topical spray for female hair loss treatment.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

CT60 polymorphism might increase the risk of Alopecia Areata.

The reviewers suggest clarifying the abstract, adding background on inflammation's effect on stem cells and cancer, discussing immune cells' role in tumors, and considering inflammation's potential to reduce cancer growth.

The revised manuscript on how inflammation affects cancer stem cells was accepted after addressing issues with clarity and detail.

Low oxygen conditions improve how well certain stem cells from embryos can make hair grow longer and faster.

Higher levels of retinol-binding protein 4 are found in people with alopecia areata, but these levels don't relate to how severe the condition is.

Melatonin affects when and how certain genes work during the growth of goat hair follicles.

Removing a specific gene in certain skin cells causes hair loss on the body by disrupting normal hair development.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

DPP4-positive fibroblasts play a major role in producing proteins that lead to skin fibrosis.

sFRP4 partially inhibits hair regeneration, but the study needs clearer data analysis and better explanation of the process.

A protein called sFRP4 can partly inhibit hair growth.

There might be a link between male pattern baldness and a higher risk of prostate cancer and testicular cancer.

The compound was successfully made and shows potential for treating prostate cancer.

Thymosin β4 and VEGF are important for organ function and may help with blood vessel formation.

The document explains how to make a compound called 3.BETA.-Benzoyloxy-4-pregnen-16.ALPHA.,17.ALPHA.-epoxy-6,20-dione and describes its crystal structure.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

Higher FABP4 levels may help diagnose androgenetic alopecia early.

Higher RBP4 levels found in people with two types of hair loss.

Laser and light treatments show promise for hair growth but need more research.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Analog 23 is a promising compound for prostate cancer treatment.